In Brief RECQ1 helicase, a proposed target for cancer therapy, unwinds or branch migrates key intermediates of DNA repair and replication. Here, Banerjee et al. show that RECQ1 governs RPA recruitment in the context of replication dynamics in vivo to suppress DNA damage and preserve genomic stability. Banerjee et al., 2015, Current Biology 25, 2830 
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RESULTS

Biochemical Characterization of RECQ1 Aromatic Loop Mutants
Two invariant aromatic loop (AL) residues, tryptophan (W) 227 and phenylalanine (F) 231, located within the helicase core domain of full-length RECQ1 were replaced with alanine (A) (Figures 1A and S1A). Electrophoretic mobility shift assays (EMSAs) demonstrated the purified recombinant mutant RECQ1 proteins were proficient in DNA binding ( Figures 1B, 1C , and S1B). K m values for ATP hydrolysis by RECQ1-W227A and RECQ1-F231A were comparable to RECQ1-WT, suggesting normal ATP binding ( Figure 1D ). Turnover rate constants for ATP hydrolysis (k cat ) were reduced 1.6-fold for RECQ1-W227A and 2.0-fold for RECQ1-F231A ( Figure 1D ). K eff values for ATP hydrolysis as a function of DNA effector concentration for the RECQ1 proteins were comparable ( Figure 1D ), consistent with their similar K d values. The relatively modest effects of either AL substitution on RECQ1 DNA binding and ATPase led us to ask whether RECQ1 unwinding (helicase) or branch migration (BM) were affected. Both W227A and F231A showed minimal unwinding activity on a forked duplex (19 bp) DNA substrate efficiently unwound by RECQ1-WT ( Figures 1E and S1C ).
RECQ1 plays an important role in homologous recombination (HR) repair [8, 14, 25] ; therefore, we characterized the effect of RECQ1 AL mutations on BM of HR DNA intermediates. Both AL mutations almost completely eliminated RECQ1's ability to resolve a closed mobile D loop ( Figures 1F and S1D ) or open three-stranded BM structure (Figures S1F and S1G). The RECQ1 mutants displayed reduced but detectable BM activity on a four-stranded HJ substrate ( Figures 1G and S1E) . Thus, despite fairly modest effects of AL mutations on DNA binding and ATPase, AL integrity is critical for RECQ1-catalyzed BM and helicase activity.
RECQ1 AL Mutants Retain Strand Annealing and Oligomerization RECQ1, like other RecQ helicases, anneals complementary single-stranded DNA molecules in an ATP-regulated manner [8] . RECQ1-W227A annealing was very similar to RECQ1-WT ( Figures 1H, S1H , and S1I). RECQ1-F231A also performed strand annealing; however, maximal product formation was reduced. Kinetic analysis of RECQ1 strand annealing kinetics correlated with protein titrations ( Figure S1J ). Strand annealing by RECQ1-W227A or RECQ1-F231A was inhibited by ATPgS in a manner comparable to RECQ1-WT ( Figure 1H ), suggesting ATP binding induced a conformational change in the AL mutants as observed for RECQ1-WT [8, 18] , consistent with their similar K m values for ATP hydrolysis ( Figure 1D ).
ATP binding affects not only RECQ1 conformational state [8] but also oligomerization [18] . In the presence of ATP (1 mM), RECQ1 was observed to shift from a tetramer capable of strand annealing to a dimer with optimal helicase activity [19] . These observations led us to ask whether the RECQ1 AL mutant proteins behaved in a similar ATP-regulated manner. Size exclusion chromatography with 1 mM ATP present demonstrated comparable shift of wild-type and mutant RECQ1 proteins from two species of 400 kD and 200 kD to a single species of intermediate size (270 kD; Figures 1I and 1J) . We conclude that the AL mutations in full-length RECQ1 do not perturb ATP-regulated oligomerization.
RECQ1 AL Mutations Interfere with Normal Cellular Replication
Approximately 75% of endogenous RECQ1 was depleted by RECQ1-siRNA, and plasmid-based expression for either RECQ1-W227A or RECQ1-F231A in RECQ1-depleted cells was comparable to endogenous RECQ1, whereas exogenous expression of RECQ1-WT was slightly less than endogenous RECQ1 ( Slower replication causes dormant replication origin firing to compensate for the delay [26, 27] , leading us to ask whether RECQ1 deficiency resulted in elevated dormant origin firing. RECQ1-depleted cells co-transfected with empty vector displayed double the number of dormant origins fired compared to control cells or RECQ1-depleted cells exogenously expressing RECQ1-WT ( Figure 2D ). RECQ1-depleted cells expressing RECQ1-W227A or RECQ1-F231A showed a 2-fold increase in dormant origins fired. Thus, expression of either RECQ1 AL mutant failed to rescue the reduced replication fork rate and elevated dormant origin firing characteristic of RECQ1-deficient cells.
Based on the abnormal replication dynamics of RECQ1-deficient cells [10, 11, 13] (current study), we asked whether RECQ1 deficiency resulted in increased double-strand breaks (DSB) and whether expression of the RECQ1 AL mutants could restore this defect. RECQ1-depleted cells co-transfected with empty vector or plasmids encoding RECQ1-W227A or RECQ1-F231A displayed an increased percentage of cells with greater than five 53BP1 foci compared to control cells or RECQ1-depleted cells exogenously expressing RECQ1-WT (Figures 2E and 2F), indicative of DSB accumulation.
Compromised DNA Damage Resistance of RECQ1-Depleted Cells Expressing RECQ1 AL Mutants RECQ1's role in replication restart after exposure to the topoisomerase inhibitor camptothecin (CPT) [11] led us to ask whether the RECQ1 AL mutants could restore CPT resistance. Chromatin-associated wild-type or AL mutant RECQ1 in the CPT-treated RECQ1 transfected cell lines was comparable (Figure 2G) ; however, neither RECQ1 mutant restored cellular resistance to CPT (Figures 2H and 2I ). Because CPT-induced blocked replication forks are known to incur single-stranded and doublestranded DNA breaks [28] and RECQ1-deficient cells are sensitive to hydrogen peroxide (H 2 O 2 ) that induces strand breaks and oxidative damage [15] , we tested for H 2 O 2 sensitivity and found that neither RECQ1 AL mutant could restore viability to the level of control cells or RECQ1-depleted cells exogenously expressing RECQ1-WT ( Figure 2J ).
RECQ1 Suppresses Dormant Origin Firing and Maintains
Free RPA Pool Dormant origin firing was shown to cause replication protein A (RPA) recruitment to sites of nascent DNA synthesis, thereby exhausting the global RPA pool, resulting in single-stranded DNA exposure vulnerable to strand breaks [29] . This led us to investigate whether RECQ1 played a role in determining RPA availability during the DNA damage response. RPA foci were induced upon CPT challenge in RECQ1-proficient HeLa cells ( Figures  3A and S2B) . However, cells depleted of endogenous RECQ1 and transfected with either blank vector or RECQ1 AL mutant poorly formed RPA foci upon CPT exposure ( Figures 3A and  S2B ). Exogenous RPA expression ( Figure S2A ) restored formation of CPT-induced RPA foci in RECQ1-depleted cells ( Figures  3B and S2B) . MRE11 foci were able to form in CPT-treated RECQ1-depleted cells, suggesting that there was not a defect upstream of RPA ( Figure 3C ). In contrast, the downstream player RAD51 poorly formed foci in CPT-treated RECQ1-deficient cells ( Figures 3D and S2C ). Spontaneous 53BP1 foci were reduced in cells overexpressing RPA in the RECQ1-depleted condition ( Figures 3E and 3F) , suggesting that DNA damage accumulation in RECQ1-deficient cells is due to RPA sequestration by nascent DNA synthesis sites at activated dormant origins.
Dominant Negative Phenotypes Exerted by RECQ1 AL Mutants
Given the importance of tumor suppressor heterozygosity in cancer [30] [31] [32] , we assessed whether the RECQ1 AL mutants exerted dominant-negative effects. HeLa cells transfected with wild-type or mutant RECQ1 expression constructs showed a 2-fold increase of RECQ1 protein compared to cells transfected with empty vector ( Figure 4A ). DNA fiber analysis demonstrated that expression of RECQ1-W227A or RECQ1-F231A in the wild-type background resulted in shorter replication tract lengths ( Figures 4B and 4C) . Consistent with slower replication, dormant origin firing in cells expressing either RECQ1 mutant was increased 2-fold ( Figure 4D) .
The abnormal replication dynamics of HeLa cells expressing RECQ1-W227A or RECQ1-F231A led us to examine their growth. Cells expressing RECQ1-W227A or RECQ1-F231A displayed greater proliferation compared to cells transfected with empty vector and at a level comparable to cells exogenously expressing RECQ1-WT ( Figure 4E ). It was reported that RECQ1 depletion resulted in slow growth of cancer cells accompanied by reduced DNA synthesis [14] , consistent with slower fork progression; therefore, it was surprising to find that RECQ1 AL mutant expression increased cell proliferation given their negative effect on replication tract length ( Figures 4B and 4C) , suggesting a possible defect in checkpoint activation. CPT-treated HeLa cells (legend continued on next page) expressing either RECQ1 AL mutant displayed decreased phosphorylated Chk1S345 ( Figure 4F ) and Chk1S317 or Chk2T68 ( Figures S3A and S3B ). Consistent with a checkpoint defect, CPT-treated cells expressing the RECQ1 AL mutant did not show an increased S phase population ( Figure S3C ). HeLa cells expressing either RECQ1 AL mutant showed significantly greater spontaneous DNA damage compared to cells transfected with empty vector or RECQ1-WT plasmid ( Figures  4G and 4H) . Moreover, RECQ1-W227A or RECQ1-F231A expressed in a wild-type RECQ1 background rendered cells more sensitive to either CPT ( Figures S3D and S3E ) or H 2 O 2 (Figure S3F) , also observed for DSB induction (Figures S3G-S3J) . CPT-treated HeLa cells expressing RECQ1 AL mutants failed to form discreet RPA foci; however, exogenous RPA expression alleviated this effect ( Figure S3K ). Formation of RAD51 foci (Figure S3K ), but not MRE11 foci (data not shown), was impaired by expression of RECQ1 AL mutants, consistent with a direct effect on free RPA pool.
Biochemical Mixing Experiments with Mutant and Wild-Type RECQ1 Proteins
In vitro mixing experiments with RECQ1-WT and either RECQ1-W227A or RECQ1-F231A were performed to assay effects on HJ resolution or forked duplex DNA unwinding. The presence of either RECQ1 AL mutant in reaction mixtures with RECQ1-WT inhibited unwinding of forked duplex DNA; however, inhibition on the HJ substrate was only observed in conversion of splayed arm product to single-stranded DNA, not HJ BM (Figures S3L-S3S ). The RECQ1 AL mutants retained HJ substrate binding (Figure S3T) , consistent with their residual HJ BM activity ( Figures  1G, S1E , and S3L-S3O). Taking together these and published results [19] , we conclude that either RECQ1 AL mutant protein poisons forked duplex unwinding by RECQ1 dimer (and possibly monomer), but not HJ BM catalyzed by RECQ1 tetramer.
DISCUSSION
Biochemical characterization of RECQ1-W227A or RECQ1-F231A revealed a critical role of the conserved AL to couple ATP hydrolysis to DNA BM or helicase activity. The severe reduction of RECQ1 BM despite a modest reduction in ATPase activity suggests that the surface-exposed AL of RECQ1 may very well interact with single-stranded DNA during concomitant ATPase-dependent coupled strand separation and annealing, consistent with predictions from analysis of truncated RECQ1-DNA crystal structures [19, 20] (Figure S1J) .
The reduced replication kinetics of RECQ1 AL-mutantexpressing cells is accompanied by increased dormant origin firing, presumably to help them complete DNA synthesis in a timely manner during S phase. Reduced replication rate is also likely to contribute to elevated DSBs. Nascent DNA synthesis at dormant origins activated as a result of slow replication fork progression in cells expressing either RECQ1 AL mutant sequester free RPA, thereby exposing single-stranded DNA and making it more vulnerable to damage. RECQ1-depleted cells expressing RECQ1 AL mutant protein show increased sensitivity to DNA damage induced by H 2 O 2 or collision of replication forks with CPT drug-topoisomerase complexes [33, 34] , suggesting for the first time that catalytic strand separation activities of RECQ1 are required for a robust DNA damage response. Based on the elevated sister chromatid exchange and IR sensitivity of RECQ1-deficient mouse embryonic fibroblasts [13] or human cells [14] , we propose that RECQ1 supports or facilitates HR repair of frank or replication-associated DSBs, consistent with its ability to BM HJs [8] and D loop intermediates [25] . Furthermore, RECQ1 governs the RPA-mediated response to replication stress to maintain chromosomal stability.
Expression of either RECQ1 AL mutant in a genetic background of wild-type RECQ1 resulted in reduced replication rate accompanied by increased dormant origin firing, elevated DSBs, and compromised H 2 O 2 or CPT resistance, similar to that observed for RECQ1-depleted cells expressing either AL mutant. Biochemical mixing experiments demonstrated that either RECQ1 AL mutant poisoned DNA unwinding by RECQ1-WT, presumably by hetero-oligomerization or static mutant RECQ1-DNA complexes. Further studies are required to ascertain mechanism of helicase inhibition and dominant-negative effects in vivo.
Our finding that cancer cells expressing helicase-defective RECQ1 accumulate DNA damage and bypass replication checkpoint suggests that RECQ1 variants may contribute to tumorigenesis. RECQ1 overexpression is observed in glioblastomas and ovarian cancers and suggested to play a role in tumor cell proliferation [35] [36] [37] . Several RECQ1 polymorphisms are associated with lower pancreatic cancer survival [38] , and RECQ1 is a proposed therapeutic target and proliferative marker for head and neck squamous cell carcinoma [39] and hepatocellular carcinoma [39, 40] . The growth advantage of cancer cells expressing catalytically defective mutant RECQ1 is most likely through a mechanism involving checkpoint bypass distinct from that involving overexpression of wild-type RECQ1, which probably helps cancer cells cope with replicative lesions.
Clinically important missense mutations have been identified in helicase genes [41] . RECQ1 missense variants reside in the core helicase domain (http://www.ncbi.nlm.nih.gov/SNP/ snp_ref.cgi?locusId=5965; Figure S3U ) and adjacent to the AL (http://exac.broadinstitute.org/gene/ENSG00000004700). RECQ1 SNPs may contribute to tumorigenesis [42] or act as genetic modifiers to influence pathogenesis, as proposed for other DNA damage response proteins [43] .
Given that CPT-induced replication blocks closely mimic the spectra of normal spontaneously collapsed replication forks [44] , our studies are informative for understanding how RECQ1 helps cancer cells deal with endogenous replication stress. RECQ1 directs a productive RPA-dependent response to endogenous replication stress by ensuring a normal replication rate and suppressing dormant origin firing. By maintaining the global RPA pool, RECQ1 provides cancer cells an opportunity to protect exposed single-stranded DNA in periods of heightened replication stress to enable fork progression. Further work may help to elucidate mechanisms of RECQ1 that could be targeted for inhibition in anti-cancer therapies. 
EXPERIMENTAL PROCEDURES
Plasmids and Cell Lines RECQ1 site-directed mutagenesis was performed using pFastBac-RECQ1 as template by Loftstrand Lab. RECQ1 cDNAs were cloned into pFLAG-CMV-2 expression vector from Sigma. HeLa cells were from ATCC. pGFP-RPA expression plasmids were kindly provided by Dr. M. Wold (University of Iowa).
Recombinant Proteins
Full-length His-tagged RECQ1 recombinant proteins were purified as described in Supplemental Experimental Procedures.
Size Exclusion Chromatography
Size exclusion chromatography was performed with purified RECQ1 proteins using a 24 ml Superdex 200 size exclusion column (GE Healthcare) by AKTA FPLC (GE Healthcare; Supplemental Experimental Procedures).
DNA Substrates
The 19-bp forked duplex and HJ(X12) DNA substrates were prepared as described [8] . Mobile D loops and open three-stranded DNA substrates were prepared by sequential annealing [25] (Supplemental Experimental Procedures).
DNA Helicase and BM Assays DNA helicase [8] and BM assays for HJ [8] , three-stranded open [25] , and D loop [25] DNA substrates were as described.
DNA Binding and Strand Annealing Assays
DNA binding and strand annealing assays were as previously described [8] .
ATP Hydrolysis Assays ATP hydrolysis was measured using [g-32P] ATP (PerkinElmer Life Sciences) and analyzed by thin-layer chromatography on polyethyleneimine-cellulose plates (Mallinckrodt Baker; Supplemental Experimental Procedures).
DNA Spreading
Replication track analyses were performed as described in Supplemental Experimental Procedures.
Immunostaining
Immunostaining of transfected cells treated was performed as described in Supplemental Experimental Procedures.
Survival Assays
Cell viability assays were performed using WST-1 reagent (Roche) according to manufacturer's protocol.
Chromatin Fractionation
Chromatin fractionation was performed using the Subcellular Protein Fractionation Kit for Cultured Cells (Thermo Scientific) according to manufacturer's protocol. Western blots were done using antibodies against RECQ1 (Santa Cruz Biotechnology), Topoisomerase I (BD Biosciences), and Histone H3 (Abcam). 
